Command Palette

Search for a command to run...

Lactose (India) Ltd.
122(-1.01%)
1W: -2.03%

Lactose (India) Peer Comparison

Snapshot Summary

Lactose (India) Ltd. shows significantly poorer performance metrics compared to its peers, with zero growth and profitability indicators. This positions it as a laggard in a competitive pharmaceuticals sector that boasts companies with robust growth, strong profitability, and reasonable valuations.

  • Lactose (India) Ltd. has no revenue growth, EPS, or profitability metrics.
  • Top peers like Sun Pharma and Cipla show strong revenue growth and profitability, while Lactose struggles significantly.
  • Valuation metrics for Lactose indicate overvaluation compared to its lack of growth and profitability.
  • Sun Pharmaceutical Industries Ltd.: Strong revenue growth (8.42% YoY), high profitability (ROE of 16.13%), and reasonable PEG at 4.91.
  • Cipla Ltd.: Consistent revenue growth (13.28% YoY), strong profitability metrics (ROE of 16.63%), and attractive PEG at 0.35.
Stocks
CMP
Market Cap
P/E
ROCE (%)
Debt/Equity
Lactose (India) Ltd.₹115.50₹145.40Cr28.16--
SUNPHARMA₹1,563.35₹3,75,099.26Cr87.5917.60%0.04
DIVISLAB₹6,091.05₹1,61,698.50Cr73.2016.46%-
CIPLA₹1,587.60₹1,28,217.27Cr23.7322.77%0.01
TORNTPHARM₹3,581.55₹1,21,215.77Cr61.5324.28%0.57
DRREDDY₹1,280.30₹1,06,835.27Cr15.5026.86%0.07
MANKIND₹2,518.95₹1,03,926.59Cr55.1828.38%0.02

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.